+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ocrevus"

Ocrevus 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Ocrevus 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Ocrevus - Drug Insight, 2019 - Product Thumbnail Image

Ocrevus - Drug Insight, 2019

  • Report
  • July 2019
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • February 2018
  • 199 Pages
From
Drug Analysis: Ocrevus - Product Thumbnail Image

Drug Analysis: Ocrevus

  • Drug Pipelines
  • November 2017
  • 14 Pages
From
CNS Therapeutics - Market Analysis, Trends, and Forecasts - Product Thumbnail Image

CNS Therapeutics - Market Analysis, Trends, and Forecasts

  • Report
  • January 2020
  • 978 Pages
From
Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 356 Pages
From
Ublituximab - Product Thumbnail Image

Ublituximab

  • Report
  • January 2019
  • 43 Pages
From
Copaxone 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Copaxone 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Lemtrada 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Lemtrada 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Zinbryta 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Zinbryta 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Tysabri 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Tysabri 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Rebif 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Rebif 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Gilenya 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Gilenya 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Plegridy 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Plegridy 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Aubagio 2018 U.S. Promotional Audit Report - Product Thumbnail Image

Aubagio 2018 U.S. Promotional Audit Report

  • Report
  • July 2019
  • 17 Pages
From
Multiple Sclerosis (MS) - Market Insights, Epidemiology and Market Forecast-2027 - Product Thumbnail Image

Multiple Sclerosis (MS) - Market Insights, Epidemiology and Market Forecast-2027

  • Drug Pipelines
  • December 2018
  • 100 Pages
From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 Pages
From
Multiple Sclerosis Forecast and Market Analysis to 2025 - Product Thumbnail Image

Multiple Sclerosis Forecast and Market Analysis to 2025

  • Report
  • July 2018
  • 765 Pages
From
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • June 2018
  • 167 Pages
From
Global Multiple Sclerosis Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Multiple Sclerosis Market Research and Forecast 2018-2023

  • Report
  • April 2018
From
Loading Indicator
adroll